These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20427690)

  • 1. Integration of epidermal growth factor receptor inhibitors with preoperative chemoradiation.
    Debucquoy A; Machiels JP; McBride WH; Haustermans K
    Clin Cancer Res; 2010 May; 16(10):2709-14. PubMed ID: 20427690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiepidermal growth factor receptor radiosensitizers in rectal cancer.
    Glynne-Jones R; Mawdsley S; Harrison M
    Anticancer Drugs; 2011 Apr; 22(4):330-40. PubMed ID: 21346551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors.
    Sartor CI
    Nat Clin Pract Oncol; 2004 Dec; 1(2):80-7. PubMed ID: 16264825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer.
    Mendelsohn J; Baselga J
    J Clin Oncol; 2003 Jul; 21(14):2787-99. PubMed ID: 12860957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.
    Modjtahedi H; Essapen S
    Anticancer Drugs; 2009 Nov; 20(10):851-5. PubMed ID: 19826350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor biology in head and neck cancer.
    Kalyankrishna S; Grandis JR
    J Clin Oncol; 2006 Jun; 24(17):2666-72. PubMed ID: 16763281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.
    Bianco C; Bianco R; Tortora G; Damiano V; Guerrieri P; Montemaggi P; Mendelsohn J; De Placido S; Bianco AR; Ciardiello F
    Clin Cancer Res; 2000 Nov; 6(11):4343-50. PubMed ID: 11106252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy.
    Ang KK; Andratschke NH; Milas L
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):959-65. PubMed ID: 14967456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline polymorphisms may act as predictors of response to preoperative chemoradiation in locally advanced T3 rectal tumors.
    Spindler KL; Nielsen JN; Lindebjerg J; Jakobsen A
    Dis Colon Rectum; 2007 Sep; 50(9):1363-9. PubMed ID: 17661145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor inhibitors in development for the treatment of non-small cell lung cancer.
    Heymach JV; Nilsson M; Blumenschein G; Papadimitrakopoulou V; Herbst R
    Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4441s-4445s. PubMed ID: 16857825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining molecular therapeutics with radiotherapy for head and neck cancer.
    Riesterer O; Milas L; Ang KK
    J Surg Oncol; 2008 Jun; 97(8):708-11. PubMed ID: 18493923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress?
    Raben D; Bianco C; Milas L; Ang KK
    Semin Radiat Oncol; 2004 Apr; 14(2):139-52. PubMed ID: 15095260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents.
    Tabernero J
    Mol Cancer Res; 2007 Mar; 5(3):203-20. PubMed ID: 17374728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy.
    Bianco R; Troiani T; Tortora G; Ciardiello F
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S159-71. PubMed ID: 16113092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): simple drugs with a complex mechanism of action?
    Normanno N; Maiello MR; De Luca A
    J Cell Physiol; 2003 Jan; 194(1):13-9. PubMed ID: 12447985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling through the epidermal growth factor receptor during the development of malignancy.
    Grandis JR; Sok JC
    Pharmacol Ther; 2004 Apr; 102(1):37-46. PubMed ID: 15056497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results.
    Baumann M; Krause M
    Radiother Oncol; 2004 Sep; 72(3):257-66. PubMed ID: 15450723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of targeted therapy to the neoadjuvant chemoradiation of rectal cancer.
    Torino F; Sarmiento R; Gasparini G
    Crit Rev Oncol Hematol; 2013 Sep; 87(3):283-305. PubMed ID: 23478150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of EGFR inhibitors with radiochemotherapy.
    Nyati MK; Morgan MA; Feng FY; Lawrence TS
    Nat Rev Cancer; 2006 Nov; 6(11):876-85. PubMed ID: 17036041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.